PTGS2 and COVID-19: Further causative components participate in worsening the management of the COVID-19 emergency, yet a leading role should be adopting a pharmacological strategy in mild COVID-19 patients with only pain-relief drugs instead of COX-2 inhibitors and anti-aggregate drugs such as acetylsalicylic acid (ASA) [11,12,13,14,15].